Session III of the Second International Colloquium on Cardio-Oncology focused on the diagnosis, management, and prevention of cardiovascular toxicity of cancer drugs. With a large menu of biomarkers and imaging modalities available to the cardio oncologist, there continues to be no consensus regarding the best use of each modality alone and in combination and whether we can actually prevent early and late cardiotoxicity using these tests to guide a preventive strategy. It has become increasingly clear that early diagnosis and intervention leads to less late cardiotoxicity and fewer cardiac-related events. This can be accomplished by taking a thorough history and performing a goal directed physical examination coupled with use of biomarkers and imaging studies. This session attempted to provide rationale for a current and integrated approach to these issues.

中文翻译：

---

患者的心脏肿瘤治疗。

第二届国际肿瘤学国际学术讨论会第三场会议的重点是癌症药物的心血管毒性的诊断，管理和预防。心脏病专家可以使用大量的生物标志物和影像学检查方法，就如何单独使用或结合使用这些方法以及我们是否可以通过这些测试来指导预防策略实际上是否可以预防早期和晚期心脏毒性，仍未达成共识。 。越来越清楚的是，早期诊断和干预导致较少的晚期心脏毒性和较少的心脏相关事件。这可以通过进行详尽的历史记录并进行针对目标的身体检查以及使用生物标志物和影像学研究来实现。